State Stem Cell Agency ICOC Agenda 06-05-07

Day 1
Jun 4, 2007
Main Location: 

Luxe Hotel
Sunset Ballroom
11461 Sunset Boulevard
Los Angeles, CA 90049

Day 2
Jun 5, 2007
Main Location: 

UCLA
Grand Horizon Room
3rd Floor, Covel Commons, Sunset Village
330 De Neve Drive
Los Angeles, California 90024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

Regular Meeting of the ICOC to the CIRM

INDEPENDENT CITIZENS' OVERSIGHT COMMITTEE ("ICOC")
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
Date: June 4, 2007

Time:  5:00 PM - 9:30 PM (Estimated)

Location:

  • Luxe Hotel
    Sunset Ballroom
    11461 Sunset Boulevard
    Los Angeles, CA 90049
 
Date: June 5, 2007

Time:  9:30 AM - 5:00 PM (Estimated)

Location:

  • UCLA
    Grand Horizon Room
    3rd Floor, Covel Commons, Sunset Village
    330 De Neve Drive
    Los Angeles, California 90024
 

OPEN SESSION

  1. Call to Order.
  2. Pledge of Allegiance.
  3. Roll Call.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item.  Speakers are asked to limit their testimony to three (3) minutes.]

 

CONSENT ITEMS

  1. Approval of minutes from the following ICOC meetings: December 7, 2006February 15-16, 2007March 15-16, 2007 ICOC & April 10, 2007
  2. Consideration of Regulation Section 10085: Use of Fetal Tissue.
 

EXECUTIVE PRESENTATIONS

  1. Chairman’s Report.
  2. Reports from Acting President & Chief Scientific Officer.
 

ACTION ITEMS

  1. Consideration of recommendations from Grants Working Group and Facilities Working Group on Shared Laboratories and Techniques Course Grant applications.
 

CLOSED SESSION

  1. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Shared Research Laboratory Grant applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).
 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session.
  2. Continuation of consideration of recommendations from Grants Working Group and Facilities Working Group on Shared Laboratories and Techniques Course Grant applications.
  3. Consideration of the Facilities Grant Administration Policy.
 

CLOSED SESSION

  1. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

***It is expected that most of the items below this will occur on June 5, 2007***

 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session on evening of June 4th.
  2. Continuation of consideration of recommendations from Grants Working Group and Facilities Working Group on Shared Laboratories Grant
 

CLOSED SESSION

  1. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Shared Research Laboratory Grant applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).
 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session.
  2. Continuation of consideration of recommendations from Grants Working Group and Facilities Working Group on Shared Laboratories and Techniques Course Grant applications.
 

BREAK

OPEN SESSION

  1. Consideration of concept proposal for an RFA for CIRM New Faculty Awards
 

CLOSED SESSION

  1. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).
 
 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session
  2. Consideration of CIRM President’s salary.
  3. Consideration of CIRM’s 07-08 Administrative Budget.
  4. Consideration of update and recommendations from IP Task Force.
  5. Consideration of Standing Orders for Governance Subcommittee.
  6. Consideration of update and recommendations IP Task Force.
 

DISCUSSION ITEMS

  1. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine